Medical News

RSS

DOD to investigate mental health care at Camp Lejeune, also will stock morning-after pill

The Associated Press reports that, according to Rep. Walter Jones, R-N.C., "The Defense Department will investigate complaints of substandard mental health care for Marines at Camp Lejeune. ... Public questions about the quality of mental health care provided by a private contractor at the base were raised last year by the September firing of Dr. Kernan Manion, a brain trauma specialist who had complained to commanders about poor facilities, inadequate care programs and weak security.

5 Feb 2010

Centerphase Solutions and Mayo Clinic collaborate to speed up clinical trials for new medical treatments

Centerphase has entered into a collaboration with Mayo Clinic to speed the introduction of new medical treatments developed by the biopharmaceutical industry. The Company addressed the root causes historically plaguing the clinical trials process: the lack of a systematic, structured approach for evaluating and optimizing protocols and the tremendous burdens associated with trial start-up administration.

5 Feb 2010

Novus Scientific's TIGR Matrix Surgical Mesh receives FDA marketing approval

Novus Scientific Pte. Ltd today announced that the US Food and Drug Administration (FDA) has given the company 510(k) clearance to market the TIGR™ Matrix Surgical Mesh, for use in reinforcement of soft tissues where weakness exists. TIGR™ Matrix Surgical Mesh is a 100 percent resorbable, synthetic matrix, knitted from two different resorbable fibers that degrade at different rates following implantation.

5 Feb 2010

Recent releases in Global Health

A Lancet study examines childbirth practices and the relationship between these practices and maternal and perinatal outcomes in nine Asian countries, as assessed by a WHO global survey. Based on the analysis of over 107,000 deliveries, the authors conclude, "To improve maternal and perinatal outcomes, caesarean section should be done only when there is a medical indication" (Lumbiganon et al., 2/6). These findings "should help us to prioritise our strategies to reduce unnecessary interventions in childbirth," write the authors of a Lancet comment.

5 Feb 2010

Third-quarter fiscal 2010 results announced by Arcadia Resources

Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced net revenues of $26.1 million and a net loss of $3.2 million, or $0.02 per share for the fiscal third quarter ended December 31, 2009.

5 Feb 2010

Radiation oncologists push for safety standards

The New York Times: "The leading professional organization dedicated to radiation oncology has called for enhanced safety measures in administering medical radiation, including the establishment of the nation's first central database for the reporting of errors involving linear accelerators — machines that generate radiation — and CT scanners.

5 Feb 2010

EBMT honours abstract on Defibrotide in Hepatic VOD prevention with the Van Bekkum Award

Gentium S.p.A. today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study," has been awarded the Van Bekkum Award for the best abstract submitted to the physician's program for the European Group for Blood and Marrow Transplantation's (EBMT) 36th Annual Meeting, to be held in Vienna, March 21-24, 2010.

5 Feb 2010

BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients

BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime’s commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.

5 Feb 2010

IntegraMed America reports solid revenue growth for fourth-quarter and full-year 2009

IntegraMed America, Inc., the nation’s leading manager of specialty outpatient healthcare facilities in the emerging, technology-focused medical niches of fertility and vein care, today announced improved results for the fourth quarter and full-year periods ended December 31, 2009.

5 Feb 2010

Hockey player teams with Ottawa medical expert to raise awareness about meningococcal meningitis

When hockey fans converge at this Sunday's Ottawa 67's game, Garry Galley, former NHL defenseman and current analyst of Hockey Night in Canada, will team up with Dr. Gary Garber to share defense tips about the four vaccine-preventable strains of meningococcal meningitis with hockey enthusiasts at the Take a Shot for Meningitis Awareness booth. The pair will educate hockey enthusiasts and their families about meningococcal meningitis prevention and protection.

5 Feb 2010

Voila helps restore and set up public safety communication networks in Haiti relief efforts

Haiti telecom operator Voila has been busy since the January 12 earthquake providing local and international service to over a million Haitian customers and thousands of incoming relief workers. However, Voila technicians are also assisting a host of agencies – from the US Coast Guard to international NGOs – to set up or restore public safety communications networks and to launch new text services tailored specifically for disaster relief.

5 Feb 2010

First Edition: February 5, 2010

Today's headlines reflect Democrats' continuing efforts to regroup and advance a legislative strategy that includes health reforms.

5 Feb 2010

MEDNAX announces EPS for three months ended December 31, 2009

MEDNAX, Inc., the national medical group providing hospital-based neonatal, anesthesia and pediatric physician services and office-based maternal-fetal and pediatric cardiology physician services, reported earnings per share for the three months ended December 31, 2009, of $1.07 on a GAAP basis, or $1.00 per share when adjusted to exclude the favorable impact of a legal settlement and lower tax rate for the period.

5 Feb 2010

Research could help in developing protein-based vaccine against maternal malaria

Researchers at the University of Copenhagen have become the first in the world to synthesize the entire protein that is responsible for life-threatening malaria in pregnant women and their unborn children.

5 Feb 2010

GlaxoSmithKline announces reduction in the investment into treatments for pain and depression

GlaxoSmithKline today said it had posted a strong performance in a challenging year with a return to sales growth for the first time since 2007.

5 Feb 2010

BIO releases proposed policy options to support U.S. job growth

Additional Congressional action is needed to follow through on the Obama administration’s recently announced initiative to rapidly build an integrated value chain for the bioeconomy, create jobs and kick start economic growth.

5 Feb 2010

"Kin selection hypothesis" may explain homosexuality from an evolutionary point of view

Male homosexuality doesn't make complete sense from an evolutionary point of view. It appears that the trait is heritable, but because homosexual men are much less likely to produce offspring than heterosexual men, shouldn't the genes for this trait have been extinguished long ago? What value could this sexual orientation have, that it has persisted for eons even without any discernible reproductive advantage?

5 Feb 2010

10 helpful tips to safeguard Alzheimer's patients

An ID bracelet, like the one offered through the Alzheimer's Association's MedicAlert + Safe Return program, helps the police or a Good Samaritan get a missing person back home safely or medical attention.

5 Feb 2010

Prestige Brands Holdings announces results for third fiscal quarter ended December 31, 2009

Prestige Brands Holdings, Inc. today announced results for the third fiscal quarter and nine months ending December 31, 2009.

5 Feb 2010

P.A.D. Task Force Committee: BioMedix Vascular Solutions invited to participate

BioMedix Vascular Solutions, Inc. announced today that John Romans, CEO and Meg Heim, RN, Vice President of Marketing have been invited to participate as members of the P.A.D. Task Force Committee on behalf of the Governor of California, Arnold Schwarzenegger, The California Podiatric Medical Association and the California Department of Chronic Disease and Injury Prevention (CDPH). The committee will meet today, February 4th, 2010 in the California State Capitol, Governors conference room.

5 Feb 2010

Medical News

DOD to investigate mental health care at Camp Lejeune, also will stock morning-after pill

Centerphase Solutions and Mayo Clinic collaborate to speed up clinical trials for new medical treatments

Novus Scientific's TIGR Matrix Surgical Mesh receives FDA marketing approval

Recent releases in Global Health

Third-quarter fiscal 2010 results announced by Arcadia Resources

Radiation oncologists push for safety standards

EBMT honours abstract on Defibrotide in Hepatic VOD prevention with the Van Bekkum Award

BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients

IntegraMed America reports solid revenue growth for fourth-quarter and full-year 2009

Hockey player teams with Ottawa medical expert to raise awareness about meningococcal meningitis

Voila helps restore and set up public safety communication networks in Haiti relief efforts

First Edition: February 5, 2010

MEDNAX announces EPS for three months ended December 31, 2009

Research could help in developing protein-based vaccine against maternal malaria

GlaxoSmithKline announces reduction in the investment into treatments for pain and depression

BIO releases proposed policy options to support U.S. job growth

"Kin selection hypothesis" may explain homosexuality from an evolutionary point of view

10 helpful tips to safeguard Alzheimer's patients

Prestige Brands Holdings announces results for third fiscal quarter ended December 31, 2009

P.A.D. Task Force Committee: BioMedix Vascular Solutions invited to participate

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News